Position in JNJ
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$4,687,778
+$249,726 QoQ
Shares Held
18,458
+1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.26%
of 13F equity value
Holder Rank
#1,664
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aspen Investment Management Inc holds $18,932,992 across 9 Drug Manufacturers - General names. JNJ ranks #1 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
18,458 | $4,687,778 | |
| 2 | LLY |
ELI LILLY & Co
|
3,349 | $4,016,891 | |
| 3 | ABBV |
AbbVie Inc.
|
13,782 | $3,468,102 | |
| 4 | AMGN |
Amgen Inc
|
7,645 | $2,768,407 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
25,285 | $1,456,921 | |
| 6 | PFE |
Pfizer Inc
|
38,006 | $915,184 | |
| 7 | MRK |
Merck & Co., Inc.
|
6,310 | $810,835 | |
| 8 | NVS |
Novartis AG
|
3,736 | $585,505 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,687,778 | 18,458 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $4,438,052 | 18,156 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $3,760,281 | 18,170 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,774,469 | 9,570 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,422,713 | 9,314 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,626,061 | 9,805 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $1,549,024 | 10,711 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,968,542 | 12,147 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,781,544 | 12,189 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $2,032,741 | 12,850 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $2,009,250 | 12,819 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,546,201 | 16,348 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,674,803 | 16,160 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,531,150 | 16,330 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,921,791 | 16,540 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,859,943 | 17,507 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,115,478 | 17,551 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,111,095 | 17,554 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,881,332 | 16,843 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $2,467,720 | 15,280 | Shares | Sole | 2021-12-06 | |
| 2021-06-30 | $2,531,230 | 15,365 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,513,897 | 15,296 | Shares | Sole | 2021-06-10 | |
| 2020-12-31 | $2,401,618 | 15,260 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $2,296,325 | 15,424 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $2,074,151 | 14,749 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,941,904 | 14,809 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||